{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:06:40Z","timestamp":1791173200120,"version":"4.1.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","surgonc.theclinics.com","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Surgical Oncology Clinics of North America"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.soc.2015.03.014","type":"journal-article","created":{"date-parts":[[2015,4,16]],"date-time":"2015-04-16T08:15:21Z","timestamp":1429172121000},"page":"509-520","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Cancer of the Oropharynx"],"prefix":"10.1016","volume":"24","author":[{"given":"David A.","family":"Clump","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie E.","family":"Bauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Ferris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.soc.2015.03.014_bib1","first-page":"11","article-title":"Cancer statistics, 2013","volume":"63","author":"Siegel","year":"2013","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.soc.2015.03.014_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib3","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/CCO.0b013e32832f3e1b","article-title":"Oropharyngeal cancer: a potential consequence of concomitant HPV and HIV infection","volume":"21","author":"Gillison","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib4","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.1056\/NEJMoa065497","article-title":"Case-control study of human papillomavirus and oropharyngeal cancer","volume":"356","author":"D\u2019Souza","year":"2007","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2015.03.014_bib5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1200\/JCO.2007.14.1713","article-title":"Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States","volume":"26","author":"Chaturvedi","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib6","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/ijc.22851","article-title":"Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: review and meta-analysis","volume":"121","author":"Ragin","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.soc.2015.03.014_bib7","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.soc.2015.03.014_bib8","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/jnci\/djn011","article-title":"Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial","volume":"100","author":"Fakhry","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.soc.2015.03.014_bib9","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1200\/JCO.2008.20.2853","article-title":"Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck","volume":"27","author":"Lassen","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib10","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2015.03.014_bib11","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1002\/lary.21129","article-title":"Population-based analysis of oral and oropharyngeal carcinoma: changing trends of histopathologic differentiation, survival and patient demographics","volume":"120","author":"Mehta","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.soc.2015.03.014_bib12","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1097\/MLG.0b013e3181857950","article-title":"Role of surgery in limited (T1-2, N0-1) cancers of the oropharynx","volume":"118","author":"Walvekar","year":"2008","journal-title":"Laryngoscope"},{"key":"10.1016\/j.soc.2015.03.014_bib13","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/archotol.129.1.36","article-title":"Transoral laser microsurgery for squamous cell carcinoma of the base of the tongue","volume":"129","author":"Steiner","year":"2003","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib14","first-page":"32","article-title":"Transoral Laser microsurgery as primary treatment for advanced-stage oropharyngeal cancer: a United States Multicenter Study. Yearb","volume":"2012","author":"Gapany","year":"2012","journal-title":"Otolaryngol Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib15","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/cncr.23578","article-title":"Intensity-modulated chemoradiation for treatment of stage III and IV oropharyngeal carcinoma: the University of California-San Francisco experience","volume":"113","author":"Huang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2015.03.014_bib16","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/archoto.2009.185","article-title":"Oropharyngeal cancer: a case for single modality treatment with transoral laser microsurgery","volume":"135","author":"Grant","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1212\/01.WNL.0000164714.90354.7D","article-title":"Robot-assisted pharyngeal and laryngeal microsurgery: results of robotic cadaver dissections","volume":"115","author":"Hockstein","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.soc.2015.03.014_bib18","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1097\/01.MLG.0000170848.76045.47","article-title":"Transoral robotic surgery: supraglottic laryngectomy in a canine model","volume":"115","author":"Weinstein","year":"2005","journal-title":"Laryngoscope"},{"key":"10.1016\/j.soc.2015.03.014_bib19","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000088012","article-title":"Maintenance of hemostasis in transoral robotic surgery","volume":"67","author":"Hockstein","year":"2005","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"10.1016\/j.soc.2015.03.014_bib20","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/01.mlg.0000227184.90514.1a","article-title":"Transoral robotic surgery (TORS) for base of tongue neoplasms","volume":"116","author":"O\u2019Malley","year":"2006","journal-title":"Laryngoscope"},{"key":"10.1016\/j.soc.2015.03.014_bib21","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1001\/archotol.133.12.1220","article-title":"Transoral robotic surgery: radical tonsillectomy","volume":"133","author":"Weinstein","year":"2007","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/hed.20972","article-title":"Transoral robotic surgery for the management of head and neck cancer: a preliminary experience","volume":"31","author":"Genden","year":"2009","journal-title":"Head Neck"},{"key":"10.1016\/j.soc.2015.03.014_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archoto.2009.24","article-title":"Robot-assisted surgery for upper aerodigestive tract neoplasms","volume":"135","author":"Boudreaux","year":"2009","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib24","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/archoto.2010.40","article-title":"Robotic-assisted surgery for primary or recurrent oropharyngeal carcinoma","volume":"136","author":"Dean","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib25","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1177\/0194599811402172","article-title":"Outcomes of transoral robotic surgery: a preliminary clinical experience","volume":"145","author":"Hurtuk","year":"2011","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib26","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archoto.2010.191","article-title":"Transoral robotic surgery for advanced oropharyngeal carcinoma","volume":"136","author":"Weinstein","year":"2010","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib27","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/lary.20647","article-title":"Transoral robotic surgery for oropharyngeal squamous cell carcinoma: a prospective study of feasibility and functional outcomes","volume":"119","author":"Moore","year":"2009","journal-title":"Laryngoscope"},{"key":"10.1016\/j.soc.2015.03.014_bib28","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1002\/lary.21021","article-title":"Selective neck dissection and deintensified postoperative radiation and chemotherapy for oropharyngeal cancer: a subset analysis of the University of Pennsylvania transoral robotic surgery trial","volume":"120","author":"Weinstein","year":"2010","journal-title":"Laryngoscope"},{"key":"10.1016\/j.soc.2015.03.014_bib29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/hed.21688","article-title":"Transoral robotic surgery for oropharyngeal carcinoma and its impact on patient-reported quality of life and function","volume":"34","author":"Leonhardt","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/j.soc.2015.03.014_bib30","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1001\/archoto.2011.172","article-title":"Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma","volume":"137","author":"Sinclair","year":"2011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib31","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1001\/archoto.2010.250","article-title":"The role of reconstruction for transoral robotic pharyngectomy and concomitant neck dissection","volume":"137","author":"Genden","year":"2011","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jamaoto.2013.107","article-title":"Oncologic benefit of tonsillectomy in stage I and II tonsil cancer: a surveillance epidemiology and end results database review","volume":"139","author":"Holliday","year":"2013","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"10.1016\/j.soc.2015.03.014_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.soc.2015.03.014_bib34","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"A\u00a0Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2015.03.014_bib35","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per\u00a0week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.soc.2015.03.014_bib36","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/cncr.28372","article-title":"Improved survival using intensity-modulated radiation therapy in head and neck cancers: A SEER-Medicare analysis","volume":"120","author":"Beadle","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.soc.2015.03.014_bib37","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1200\/JCO.2007.11.5501","article-title":"Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients","volume":"25","author":"Kam","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S1470-2045(10)70290-4","article-title":"Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial","volume":"12","author":"Nutting","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijrobp.2010.01.019","article-title":"A\u00a0phase III trial to test accelerated versus standard fractionation in combination with concurrent cisplatin for head and neck carcinomas (RTOG 0129): report of efficacy and toxicity","volume":"77","author":"Ang","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2015.03.014_bib40","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s12094-012-0970-4","article-title":"DeCIDE and PARADIGM: nails in the coffin of induction chemotherapy in head and neck squamous cell carcinoma?","volume":"15","author":"Loo","year":"2013","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.radonc.2012.02.009","article-title":"Outcomes of HPV-related oropharyngeal cancer patients treated by radiotherapy alone using altered fractionation","volume":"103","author":"O\u2019Sullivan","year":"2012","journal-title":"Radiother Oncol"},{"issue":"Suppl 15","key":"10.1016\/j.soc.2015.03.014_bib42","doi-asserted-by":"crossref","first-page":"6005","DOI":"10.1200\/jco.2013.31.15_suppl.6005","article-title":"E\u00a01308: a phase II trial of induction chemotherapy followed by cetuximab with low dose versus standard dose IMRT in patients with human papilloma virus-associated resectable squamous cell carcinoma of the oropharynx","volume":"31","author":"Marur","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib43","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2005.06.022","article-title":"Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity","volume":"76","author":"Dittmann","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib44","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.ijrobp.2009.07.057","article-title":"Phase II randomized trial of postoperative chemoradiation plus cetuximab for high-risk squamous cell carcinoma of the head and neck (RTOG 0234)","volume":"75","author":"Kies","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.soc.2015.03.014_bib45","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2006.06.7447","article-title":"Open-label, uncontrolled, multicenter phase II study to evaluate the efficacy and toxicity of cetuximab as a single agent in patients with recurrent and\/or metastatic squamous cell carcinoma of the head and neck who failed to respond to platinum-based the","volume":"25","author":"Vermorken","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.soc.2015.03.014_bib46","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1056\/NEJMoa0802656","article-title":"Platinum-based chemotherapy plus cetuximab in head and neck cancer","volume":"359","author":"Vermorken","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.soc.2015.03.014_bib47","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-04-0054","article-title":"Decreased absolute counts of T lymphocyte subsets and their relation to disease in squamous cell carcinoma of the head and neck","volume":"10","author":"Kuss","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.soc.2015.03.014_bib48","doi-asserted-by":"crossref","first-page":"5541","DOI":"10.4049\/jimmunol.175.8.5541","article-title":"Inhibition of NK cell activity through TGF-beta 1 by down-regulation of NKG2D in a murine model of head and neck cancer","volume":"175","author":"Dasgupta","year":"2005","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.soc.2015.03.014_bib49","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/immu.200390014","article-title":"Preferential apoptosis of CD56dim natural killer cell subset in patients with cancer","volume":"33","author":"Bauernhofer","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.soc.2015.03.014_bib50","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.1158\/1078-0432.CCR-05-2750","article-title":"Immune escape associated with functional defects in antigen-processing machinery in head and neck cancer","volume":"12","author":"Ferris","year":"2006","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.soc.2015.03.014_bib51","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.4049\/jimmunol.176.6.3402","article-title":"Role of antigen-processing machinery in the in\u00a0vitro resistance of squamous cell carcinoma of the head and neck cells to recognition by CTL","volume":"176","author":"L\u00f3pez-Albaitero","year":"2006","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.soc.2015.03.014_bib52","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.soc.2015.03.014_bib53","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1126\/science.1206923","article-title":"Exome sequencing of head and neck squamous cell carcinoma reveals inactivating mutations in NOTCH1","volume":"333","author":"Agrawal","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.soc.2015.03.014_bib54","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1126\/science.1208130","article-title":"The mutational landscape of head and neck squamous cell carcinoma","volume":"333","author":"Stransky","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.soc.2015.03.014_bib55","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1158\/2159-8290.CD-13-0103","article-title":"Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers","volume":"3","author":"Lui","year":"2013","journal-title":"Cancer Discov"},{"key":"10.1016\/j.soc.2015.03.014_bib56","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/1471-2407-13-602","article-title":"PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma","volume":"13","author":"Chiosea","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.soc.2015.03.014_bib57","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1158\/1535-7163.MCT-09-0463","article-title":"Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents","volume":"8","author":"Hirai","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.soc.2015.03.014_bib58","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1158\/1535-7163.MCT-13-0157","article-title":"Chk1\/2 inhibition overcomes the cisplatin resistance of head and neck cancer cells secondary to the loss of functional p53","volume":"12","author":"Gadhikar","year":"2013","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.soc.2015.03.014_bib59","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.1158\/1078-0432.CCR-11-0650","article-title":"MK-1775, a novel Wee1 kinase inhibitor, radiosensitizes p53-defective human tumor cells","volume":"17","author":"Bridges","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.soc.2015.03.014_bib60","doi-asserted-by":"crossref","first-page":"e302","DOI":"10.1016\/S1470-2045(13)70085-8","article-title":"Novel targets in HPV-negative head and neck cancer: overcoming resistance to EGFR inhibition","volume":"14","author":"Burtness","year":"2013","journal-title":"Lancet Oncol"}],"container-title":["Surgical Oncology Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320715000393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1055320715000393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T11:59:31Z","timestamp":1760961571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1055320715000393"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S1055320715000393"],"URL":"https:\/\/doi.org\/10.1016\/j.soc.2015.03.014","relation":{},"ISSN":["1055-3207"],"issn-type":[{"value":"1055-3207","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer of the Oropharynx","name":"articletitle","label":"Article Title"},{"value":"Surgical Oncology Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.soc.2015.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}